Alnylam Pharmaceuticals' Unattributed VC - II Round

Alnylam Pharmaceuticals raised a round of funding on July 11, 2003.

Alnylam Pharmaceuticals (NASDAQ: ALNY) is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company believes that are many new therapeutic frontiers fo…

Articles about Alnylam Pharmaceuticals' Unattributed VC - II Round: